| | | ≤65 y | value | >65 y | value | | BMI | BMI | | Normal | Overweight | Obesity | Normal | Overweight | Obesity | | <24 (n = 168) | 24–28 (n = 596) | >28 (n = 228) | <24 (n = 50) | 24–28 (n = 198) | >28 (n = 189) |
| | Age, years | 52 ± 9 | 52 ± 8 | 51 ± 8 | 0.847 | 71 ± 4 | 72 ± 4 | 72 ± 4 | 0.444 | | Male, n (%) | 146 (86.9) | 492 (82.6) | 198 (86.8) | 0.187 | 34 (68.0) | 170 (85.9) | 147 (77.8) | 0.008 | | Hypertension, n (%) | 84 (50.0) | 304 (51.0) | 150 (65.8) | <0.001 | 28 (56.0) | 122 (61.6) | 108 (57.1) | 0.314 | | Diabetes mellitus, n (%) | 44 (26.2) | 124 (20.8) | 78 (34.2) | <0.001 | 8 (16.0) | 58 (29.3) | 48 (25.4) | 0.099 | | Smoking status, n (%) | | | | 0.042 | | | | <0.01 | | Current smoking | 96 (57.1) | 352 (59.1) | 144 (63.2) | | 22 (44.0) | 130 (65.7) | 129 (68.3) | | | Ex-smoking | 4 (2.4) | 28 (4.7) | 12 (5.3) | | 4 (8.0) | 4 (2.0) | 12 (6.3) | | | Never | 68 (40.5) | 216 (36.2) | 72 (31.6) | | 24 (48.0) | 64 (32.3) | 48 (25.4) | | | Previous stroke, n (%) | 6 (3.6) | 28 (4.7) | 6 (2.6) | 0.381 | 8 (14.3) | 20 (10.0) | 21 (11.1) | 0.063 | | Previous PCI, n (%) | 6 (3.6) | 36 (6.0) | 6 (2.6) | 0.088 | 2 (3.6) | 0 (0) | 0 (0) | 0.001 | | Medication before AMI, n (%) | | | | | | | | | | Aspirin | 10 (6.0) | 56 (9.4) | 30 (13.2) | 0.053 | 4 (8.0) | 16 (8.1) | 6 (3.2) | 0.207 | | ACEIs/ARBs | 18 (10.7) | 68 (11.4) | 36 (15.8) | 0.182 | 8 (16.0) | 36 (18.2) | 24 (12.7) | 0.627 | | Beta-blocker | 10 (6.0) | 56 (9.4) | 36 (15.8) | 0.003 | 12 (24.0) | 16 (8.1) | 6 (3.2) | <0.01 | | Statins | 4 (2.4) | 28 (4.7) | 12 (5.3) | 0.343 | 4 (8.0) | 4 (2.0) | 0 (0) | 0.003 | | Time-to-hospital admission, h | 13 ± 14 | 17 ± 26 | 19 ± 26 | 0.056 | 11 ± 14 | 20 ± 25 | 18 ± 27 | 0.330 | | Physical findings on admission | | | | | | | | | | SBP, mmHg | 113 ± 26 | 121 ± 17 | 121 ± 22 | <0.01 | 114 ± 27 | 118 ± 18 | 121 ± 18 | 0.551 | | DBP, mmHg | 72 ± 14 | 76 ± 12 | 76 ± 15 | 0.005 | 75 ± 11 | 73 ± 12 | 74 ± 10 | 0.553 | | HR, beats/min | 75 ± 16 | 76 ± 11 | 78 ± 19 | 0.223 | 76 ± 12 | 79 ± 18 | 78 ± 16 | 0.377 | | Glucose, mmol/L | 5.4 ± 1.9 | 7.7 ± 2.9 | 5.4 ± 2.7 | 0.521 | 4.7 ± 1.9 | 5.1 ± 2.3 | 5.4 ± 1.6 | 0.291 | | hs-CRP, mmol/L | 8.5 (0.7–42.6) | 9.6 (0.2–42.5) | 8.8 (0.2–41.2) | 0.517 | 8.1 (0.6–34.3) | 11.7 (0.9–40.9) | 10.9 (0.22–43.3) | 0.743 | | BNP, mmol/L | 68.8 (2.4–1886) | 121.7 (3.7–3217) | 99.5 (4.9–2381) | 0.415 | 5.8 (0.1–135) | 264 (39.6–3321) | 130 (2.7–2100) | 0.258 | | LDL-C, mmol/L | 2.8 ± 0.8 | 2.9 ± 0.8 | 3.0 ± 0.6 | 0.311 | 2.7 ± 0.6 | 2.9 ± 0.9 | 3.1 ± 0.7 | 0.048 | | TG, mmol/L | 1.8 ± 1.0 | 2.0 ± 1.3 | 2.4 ± 1.6 | 0.002 | 1.9 ± 1.3 | 1.9 ± 1.5 | 2.1 ± 1.1 | 0.308 | | Uric acid, umol | 300 ± 106 | 308 ± 95 | 307 ± 118 | 0.705 | 318 ± 115 | 296 ± 80 | 352 ± 110 | 0.005 | | Peak CK-MB, mU/ml | 391 ± 995 | 210 ± 200 | 209 ± 223 | 0.004 | 218 ± 188 | 237 ± 239 | 298 ± 293 | 0.141 | | Killip classes ≥2 | 132 (78.6) | 440 (73.8) | 144 (63.2) | 0.001 | 38 (76.0) | 134 (67.7) | 135 (71.4) | 0.390 | | IRA, n (%) | | | | 0.012 | | | | 0.308 | | LM | 4 (2.4) | 4 (0.7) | 0 (0) | | 0 (0) | 0 (0) | 0 (0) | | | LAD | 86 (51.2) | 296 (49.7) | 138 (60.5) | | 30 (60.0) | 104 (52.5) | 102 (54) | | | LCX | 36 (21.4) | 80 (13.4) | 18 (7.9) | | 6 (12.0) | 24 (12.1) | 42 (22.2) | | | RCA | 42 (25.0) | 216 (36.2) | 72 (31.6) | | 14 (28.0) | 68 (34.3) | 45 (23.8) | | | Triple disease, n (%) | 38 (22.6) | 152 (25.5) | 66 (28.9) | 0.351 | 18 (36.0) | 52 (26.3) | 30 (15.9) | 0.048 | | Initial TIMI flow 0, n (%) | 90 (53.6) | 356 (59.7) | 138 (60.5) | 0.303 | 36 (72.0) | 146 (73.7) | 117 (61.9) | 0.036 | | Stent length, mm | 24 ± 6 | 24 ± 6 | 25 ± 7 | 0.452 | 24 ± 6 | 24 ± 7 | 25 ± 6 | 0.804 | | Stent diameter, mm | 2.7 ± 0.9 | 2.8 ± 0.8 | 3 ± 0.7 | 0.015 | 2.9 ± 0.7 | 2.9 ± 0.6 | 2.9 ± 0.5 | 0.862 | | Echocardiography | | | | | | | | | | LVEF, % | 55 ± 11 | 54 ± 10 | 54 ± 9 | 0.898 | 53 ± 12 | 56 ± 9 | 53 ± 7 | 0.085 | | LVESD, mm | 33 ± 4 | 34 ± 7 | 35 ± 7 | 0.098 | 34 ± 4 | 31 ± 6 | 39 ± 9 | 0.004 | | LVEDD, mm | 50 ± 21 | 48 ± 7 | 49 ± 6 | 0.343 | 48 ± 3 | 48 ± 5 | 49 ± 4 | 0.357 | | LVA, n (%) | 6 (3.6) | 20 (3.4) | 12 (5.3) | 0.435 | 4 (8.0) | 12 (6.1) | 18 (9.5) | 0.235 | | Bleedings, n (%) | 22 (13.1) | 38 (6.4) | 12 (5.3) | 0.514 | 8 (16.0) | 8 (4.0) | 2 (1.1) | 0.018 | | TIMI major bleeding | 0 | 0 | 0 | | 0 | 0 | 0 | | | TIMI minor bleeding | 6 (3.6) | 12 (2.0) | 3 (1.3) | | 1 (2.0) | 0 | 0 | | | TIMI minimal bleeding | 16 (9.5) | 26 (4.4) | 9 (3.9) | | 7 (14.0) | 8 (4.0) | 2 (1.1) | |
|
|
Values are n (%) or means ± SD. BMI, body mass index; PCI, percutaneous coronary intervention; AMI, acute myocardial infarction; ACEIs, angiotensin-converting enzyme inhibitors; ARBs, angiotensin receptor blockers; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; hs-CRP, high-sensitivity C-reactive protein; BNP, B-type natriuretic peptide; LDL-C, low-density lipoprotein cholesterol; TG, triglyceride; CK, creatine kinase; IRA, infarct-related artery; LM, left main; LAD, left anterior descending artery; RCA, right coronary artery; LCX, left circumflex artery; TIMI, Thrombolysis in Myocardial Infarction grade; LVEF, left ventricular ejection fraction; LVEDD, left ventricular end-diastolic dimension; LVESD, left ventricular end-systolic diameter; LAV, left ventricular aneurysm.
|
